Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
Ikena, after tough year of layoffs, merges with Inmagene
After a year that saw Ikena trim its workforce and pipeline, the oncology biotech thinks it’s found a path forward via a merger into Inmagene.
James Waldron
Dec 23, 2024 10:00am
Rapt pays $35M for challenger to Novartis, Roche drug
Dec 23, 2024 8:10am
Sanofi pays SK $52M as children's pneumococcal shot enters ph. 3
Dec 23, 2024 8:05am
Galectin's stock halves after phase 3 MASH trial misses goal
Dec 20, 2024 2:40pm
Sanofi scoops up China rights to Cytokinetics' heart disease med
Dec 20, 2024 11:07am
Apollomics, after giving up on leukemia drug, posts ph. 3 fail
Dec 20, 2024 9:30am
